<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Neonatal thrombosis: Clinical features and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Neonatal thrombosis: Clinical features and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Neonatal thrombosis: Clinical features and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anthony KC Chan, MBBS, FRCPC, FRCPath
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mihir D Bhatt, MD, FRCPC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sarah O'Brien, MD, MSc
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph A Garcia-Prats, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 02, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thrombotic events are uncommon in newborns; however, it is increasingly recognized as a complication of contemporary neonatal care and they contribute to neonatal morbidity and mortality.
        </p>
        <p>
         The epidemiology, risk factors, clinical features, and diagnosis of neonatal thrombosis, excluding the central nervous system, are reviewed here. Central nervous system thromboembolic disease and the management of neonatal thrombosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">
          "Stroke in the newborn: Classification, manifestations, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5911.html" rel="external">
          "Neonatal thrombosis: Management and outcome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          COAGULATION IN NEWBORNS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Plasma concentrations of the components of the coagulation cascade (
         <a class="graphic graphic_figure graphicRef69920" href="/z/d/graphic/69920.html" rel="external">
          figure 1
         </a>
         ) and fibrinolytic pathway (
         <a class="graphic graphic_figure graphicRef81428" href="/z/d/graphic/81428.html" rel="external">
          figure 2
         </a>
         ) in newborns differ markedly from older children and adults. Concentrations of these factors change from birth through infancy (
         <a class="graphic graphic_table graphicRef66999" href="/z/d/graphic/66999.html" rel="external">
          table 1A
         </a>
         ) [
         <a href="#rid1">
          1-4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1371.html" rel="external">
          "Overview of hemostasis"
         </a>
         .)
        </p>
        <p>
         In newborns, the following procoagulant, anticoagulant, and fibrinolytic factors differ considerably compared with adult levels:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vitamin K-dependent coagulation factors (II, VII, IX, X) and contact factors (XI, XII, prekallikrein, high molecular weight kininogen) are 50 to 70 percent of adult levels [
         <a href="#rid5">
          5
         </a>
         ]. These factors increase rapidly after birth, reaching adult levels of most components by six months of age [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factors V, VIII, and XIII; von Willebrand factor; and fibrinogen are at least 70 percent of adult levels [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coagulation inhibitors (antithrombin, heparin cofactor II, protein C, protein S) are approximately 50 percent of adult levels [
         <a href="#rid1">
          1
         </a>
         ]. However, the concentration of alpha-2-macroglobulin is greater in newborns than in adults.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The rate of thrombin generation in newborn plasma is 30 to 50 percent of adult values [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fibrinolytic factors plasminogen and alpha-1 antiplasmin are lower than adult values [
         <a href="#rid1">
          1
         </a>
         ]. However, levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are higher.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants born preterm have even lower levels of vitamin K-dependent clotting factors as compared with those born at term (
         <a class="graphic graphic_table graphicRef65080" href="/z/d/graphic/65080.html" rel="external">
          table 1B
         </a>
         ) and also lower values for inhibitors of coagulation including antithrombin and protein C [
         <a href="#rid2">
          2,7
         </a>
         ]. Because of their immature coagulation system, preterm infants are particularly at risk for developing bleeding or thrombotic complications in response to perinatal risk factors or iatrogenic events.
        </p>
        <p>
        </p>
        <p>
         Due to the altered levels of procoagulant, anticoagulant, and fibrinolytic factors, newborns are at increased risk of bleeding or thrombotic complications compared with older children, especially in the presence of other hemostatic challenges such as indwelling catheters.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H3103360461">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reported estimates of the incidence of neonatal thrombosis range from 3 to 5 cases per 100,000 live births [
         <a href="#rid8">
          8-10
         </a>
         ]. In studies performed in the neonatal intensive care unit (NICU) setting, rates of thrombosis range from 0.7 to 1.5 percent of NICU admissions [
         <a href="#rid11">
          11-14
         </a>
         ]. Reported incidence rates of neonatal thrombosis in the contemporary era are higher than in studies from the 1990s to early 2000s. Improved detection and advances in management and survival of very preterm neonates likely explain the increase.
        </p>
        <p>
         In a large multicenter observational study involving nearly 40,000 neonates cared for at 30 NICUs in Canada from 2014 to 2016, 1.5 percent of patients had at least one documented thrombosis during their NICU stay [
         <a href="#rid14">
          14
         </a>
         ]. Among patients with thrombosis, 75 percent of cases were venous (most commonly involving the portal vein), 19 percent were arterial (most commonly arterial stroke), and 5 percent were mixed.
        </p>
        <p class="headingAnchor" id="H2423394820">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important risk factors for thrombosis in newborns include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Central venous or arterial catheter – Thrombosis occurs in up to 10 percent of neonates with central venous catheters; however, most of these are asymptomatic [
         <a href="#rid15">
          15
         </a>
         ]. Arterial thrombosis occurs in up to 20 percent of neonates with umbilical arterial catheters (UACs) [
         <a href="#rid16">
          16
         </a>
         ]. The risk of thrombosis is influenced by location of the catheter (femoral location has the greatest risk) and how long the catheter remains in place [
         <a href="#rid13">
          13,14,17-19
         </a>
         ]. (See
         <a class="local">
          'Catheter-associated thrombosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Polycythemia [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Major surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other underlying conditions (eg, metabolic disorders, congenital heart disease, congenital nephrotic syndrome) [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inherited thrombophilia– The inherited thrombophilias for which the pathogenic link is most clearly established include [
         <a href="#rid23">
          23-25
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antithrombin deficiency
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Protein C deficiency
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Protein S deficiency
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Factor V Leiden mutation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prothrombin G20210A
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, the incidence of these disorders in newborns with thrombosis is not known and the contribution of the prothrombotic state to the pathogenesis of neonatal thrombosis is uncertain [
         <a href="#rid26">
          26
         </a>
         ]. The approach to testing for thrombophilia in a newborn with clinically significant thrombosis is discussed below. (See
         <a class="local">
          'Additional testing'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical presentation of thrombosis is variable. Signs and symptoms depend upon the location and size of the thrombus. The most common predisposing factor for thrombosis is the presence of a central venous or arterial catheter [
         <a href="#rid8">
          8,9
         </a>
         ]. For thromboses unrelated to a catheter, renal vein thrombosis (RVT) is the most common location [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2423394300">
         <span class="h2">
          Catheter-associated thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central venous catheters are usually placed through the umbilical vein or major vessels such as the jugular vein. Peripherally inserted central catheters are placed through peripheral veins in the arms, legs, or scalp. Central venous catheters are widely used to provide intravenous fluids, parenteral nutrition, and medications to term and preterm infants who require intensive care. In a series of 193 infants with central venous catheters, central venous or intracardiac thrombosis occurred in 13 percent [
         <a href="#rid27">
          27
         </a>
         ]. The location of the tip of the catheter may have an effect on the incidence of thrombosis.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Venous thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many cases of venous thrombosis are asymptomatic and detected incidentally [
         <a href="#rid23">
          23,28
         </a>
         ]. Most are associated with central venous catheters [
         <a href="#rid8">
          8,22,24
         </a>
         ]. The presenting sign may be loss of patency of the catheter. Other signs may include swelling and/or color changes in the affected extremity.
        </p>
        <p>
         Symptomatic thrombosis in the inferior vena cava typically presents as swelling of the lower limbs and lower body [
         <a href="#rid29">
          29
         </a>
         ]. Superior vena cava thrombosis typically presents as swelling of the arm, neck, and head. The severity of the swelling depends upon the size of the thrombus. Chylothorax may be the presenting sign of superior vena cava thrombosis [
         <a href="#rid30">
          30-32
         </a>
         ].
        </p>
        <p>
         Long-term complications of neonatal venous thromboembolic disease depend upon the location:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Portal vein thrombosis (PVT) may result in portal hypertension. (See
         <a class="local">
          'Portal vein thrombosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RVT can cause systemic hypertension and/or chronic kidney disease. (See
         <a class="local">
          'Renal vein thrombosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Occlusive deep venous thrombosis (DVT) can result in post-thrombotic syndrome (PTS), a disorder characterized by edema and impaired viability of subcutaneous tissue in an extremity. PTS is increasingly recognized in older infants and children, but it is less common following neonatal thrombosis. (See
         <a class="medical medical_review" href="/z/d/html/5911.html" rel="external">
          "Neonatal thrombosis: Management and outcome", section on 'Outcome'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5916.html" rel="external">
          "Venous thrombosis and thromboembolism (VTE) in children: Treatment, prevention, and outcome", section on 'Post-thrombotic syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4012691074">
         <span class="h3">
          Portal vein thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the neonate, umbilical venous catheterization is associated with an increased risk of PVT [
         <a href="#rid33">
          33-37
         </a>
         ]. Most cases are asymptomatic and regress spontaneously.
        </p>
        <p>
         Reported rates of PVT in studies using routine ultrasound surveillance for all patients with umbilical venous catheters range from 22 to 75 percent [
         <a href="#rid38">
          38-40
         </a>
         ]. In these studies, spontaneous resolution at one year was &gt;95 percent among patients who underwent serial ultrasound monitoring [
         <a href="#rid38">
          38,40
         </a>
         ].
        </p>
        <p>
         Most PVTs in neonates are asymptomatic and do not have long-term consequences. However, a small minority of patients may develop long-term complications such as hepatic lobar atrophy and/or portal hypertension [
         <a href="#rid33">
          33,36,41-44
         </a>
         ]. The precise incidence of and risk factors for these complications are unknown. In a retrospective study of 74 patients with neonatal PVT, 60 percent had complete resolution demonstrated on sequential ultrasound imaging over an average follow-up of 16 months; the remaining 40 percent had either partial resolution or stable appearance on follow-up ultrasound [
         <a href="#rid44">
          44
         </a>
         ]. In this study, only 4 percent of patients experienced complications of PVT (hepatomegaly in two patients, splenomegaly in one patient); no patients in this series developed lobar atrophy or portal hypertension. By contrast, an earlier study of 133 patients with neonatal PVT reported higher rates of hepatic lobar atrophy (23 percent) and portal hypertension (4.5 percent) [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2423394033">
         <span class="h3">
          Right atrial thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Right atrial thrombosis is associated with central venous catheter placement. In one report, this disorder was detected by prospective echocardiography in the first few days after birth in 4 of 76 (5 percent) very low birth weight infants who had umbilical catheters [
         <a href="#rid45">
          45
         </a>
         ]. Symptomatic intracardiac thrombosis can present as a new murmur or heart failure, as well as malfunction of the catheter [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2423394106">
         <span class="h3">
          Arterial thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nearly all cases of arterial thrombosis in neonates are associated with arterial catheters [
         <a href="#rid16">
          16,24
         </a>
         ]. Umbilical arterial catheters (UACs) and peripheral arterial catheters (radial, posterior tibial) are typically used for monitoring of blood pressure and blood gases; the femoral artery is often used for cardiac catheterization.
        </p>
        <p>
         The incidence of arterial thrombosis associated with arterial catheters in neonates is variable and depends in part upon the method of detection used. In a systematic review of 22 observational studies, the pooled incidence of catheter-related arterial thrombosis in neonates with arterial catheters was 21 percent [
         <a href="#rid16">
          16
         </a>
         ]. Presenting signs may include evidence of acute limb ischemia (ie, pale or discolored extremity) and/or arterial hypertension [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         Prophylactic heparin infusion into arterial catheters may reduce the risk of thrombosis, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5911.html" rel="external">
          "Neonatal thrombosis: Management and outcome", section on 'Prevention of catheter-associated thrombosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Umbilical artery catheter
         </strong>
         s – The reported incidence of arterial thrombosis in neonates with UACs in place is approximately 8 to 20 percent [
         <a href="#rid16">
          16,39,46
         </a>
         ]. Most UAC-associated thromboses are asymptomatic. However, some present with signs of severe ischemia or organ dysfunction. Depending upon the location of the thrombus, signs can include coolness; poor perfusion; and blanching of a toe, one or both limbs, or the buttocks. Hypertension may also be noted. In some cases, the presentation can mimic that of severe aortic coarctation. (See
         <a class="medical medical_review" href="/z/d/html/5760.html" rel="external">
          "Clinical manifestations and diagnosis of coarctation of the aorta"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Renal failure, necrotizing enterocolitis, and spinal cord infarction are rare complications of UAC-associated thrombosis that can occur if the thrombosis extends into the renal, mesenteric, or branches of the spinal arteries [
         <a href="#rid47">
          47-49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Peripheral arterial catheters
         </strong>
         – Clinical signs of peripheral arterial thrombosis include decreased or absent peripheral pulses; diminished perfusion of the distal extremity with a prolonged capillary refill time; and a cool, pale extremity. Severe thrombosis in an extremity can result in long-term arterial insufficiency. This may impair growth of the affected limb [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Renal vein thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         RVT accounts for approximately 10 percent of venous thrombosis in newborns and is the most common form of neonatal thrombosis not associated with a vascular catheter [
         <a href="#rid8">
          8,51
         </a>
         ].
        </p>
        <p>
         The proposed mechanisms resulting in RVT include reduced renal blood flow, hyperosmolality, hypercoagulability, and increased blood viscosity [
         <a href="#rid52">
          52,53
         </a>
         ]. Risk factors associated with RVT include prematurity, perinatal asphyxia, shock, dehydration, sepsis, polycythemia, cyanotic congenital heart disease, respiratory distress syndrome, and maternal diabetes [
         <a href="#rid51">
          51,52,54,55
         </a>
         ]. In addition, the prevalence of inherited thrombophilia (eg, antithrombin deficiency, protein C or S deficiency, factor V Leiden mutation, and prothrombin G20210A) is higher in infants with RVT compared with the general population [
         <a href="#rid52">
          52,55
         </a>
         ].
        </p>
        <p>
         RVT, which may occur as an extension of inferior vena cava thrombosis, typically presents with one of the following cardinal features of RVT: flank mass, hematuria, or thrombocytopenia. However, in one series of 23 cases of which 83 percent were diagnosed in the first month after birth, the complete triad was seen in only 13 percent [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         The clinical presentation of neonatal RVT was demonstrated by a systematic review of the literature from 1992 to 2006 that identified 271 patients from 13 case series [
         <a href="#rid57">
          57
         </a>
         ]. The following findings were noted:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The time of presentation varied and occurred in utero (7 percent), by three days of life (67 percent), and after three days of life but before one month of age (26 percent). Most of the patients were born full term (71 percent), and there was a male predominance (67 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients had one or more of the following findings at presentation: gross hematuria (56 percent), thrombocytopenia (48 percent), and/or a palpable abdominal mass (45 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Approximately 70 percent of cases were unilateral, which involved the left kidney in two-thirds of these patients.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The thrombus extended into the inferior vena cava in approximately 44 percent of patients, and adrenal hemorrhage occurred in 15 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Perinatal risk factors including asphyxia were identified in 32 percent of cases. Other reported risk factors included maternal diabetes mellitus (8 percent) and dehydration (2 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among the 149 patients in whom prothrombotic factors were investigated, 53 percent had at least one risk factor identified.
        </p>
        <p>
        </p>
        <p>
         Long-term sequelae of RVT include systemic hypertension and chronic kidney disease [
         <a href="#rid51">
          51,56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Purpura fulminans
         </span>
         <span class="headingEndMark">
          —
         </span>
         Purpura fulminans in newborns is a rare, life-threatening condition characterized by disseminated intravascular coagulation and hemorrhagic skin necrosis [
         <a href="#rid58">
          58
         </a>
         ]. It usually is caused by homozygous or compound heterozygous deficiency in protein C or S, a mechanism that is consistent with the observation of consanguinity in some affected families [
         <a href="#rid58">
          58-64
         </a>
         ]. The heterozygous parents of these infants have type 1 protein C deficiency but infrequently have a history of thrombosis.
        </p>
        <p>
         Purpura fulminans also can result from acquired protein C deficiency due to consumptive coagulopathy, as in meningococcemia [
         <a href="#rid58">
          58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1300.html" rel="external">
          "Clinical manifestations of meningococcal infection", section on 'Purpura fulminans'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1354.html" rel="external">
          "Protein C deficiency", section on 'Control of protein C levels'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H377709236">
         <span class="h3">
          Clinical presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal purpura fulminans usually occurs on the first day of life. Affected infants present with ecchymoses, extensive venous and arterial thromboses (initially at sites of trauma), laboratory evidence of disseminated intravascular coagulation (thrombocytopenia, hypofibrinogenemia, and increased prothrombin time and activated partial thromboplastin time times), and extremely low levels of protein C or protein S antigen (less than 1 percent of normal) [
         <a href="#rid59">
          59-61,65-70
         </a>
         ]. Delayed presentation of the disorder (after six months of age) has been reported [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H377709478">
         <span class="h3">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of protein C or S deficiency is made by testing a citrated plasma sample for protein C and S activity [
         <a href="#rid58">
          58
         </a>
         ]. The sample must be collected prior to initiation of treatment, but treatment should not be delayed while awaiting the results. Results should be compared with age-specific reference ranges because protein C and S activity in healthy neonates is substantially lower than in older children or adults [
         <a href="#rid1">
          1,2
         </a>
         ]. Ideally, the diagnosis is confirmed with genetic testing; a list of clinical laboratories that perform genetic testing for this disorder is available at the
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2FGeneTests%2Flab%2Fclinical_disease_id%2F260112%3Fdb%3Dgenetests&amp;token=jDMGUAr9sjeNbmBST0GTdmOfU%2BkMf6xxxBHZ75ak0%2FG85TiGTxg2Fg3%2BVCoj6GCL%2Fx1N0IHgSh3aiwqA8%2F3NagYZtOB325ZuAj5tH5U8u63st9lywQ%2B1vo%2FVbEPIViTI&amp;TOPIC_ID=5912" target="_blank">
          GeneTests website
         </a>
         .
        </p>
        <p class="headingAnchor" id="H2423394278">
         <span class="h1">
          ASSOCIATION WITH THROMBOCYTOPENIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neonatal thrombosis is often associated with thrombocytopenia. Thus, the diagnosis of thrombosis should be considered in neonates with thrombocytopenia who lack an alternative explanation for the low platelet count. Other causes of neonatal thrombosis are summarized in the table (
         <a class="graphic graphic_table graphicRef52668" href="/z/d/graphic/52668.html" rel="external">
          table 2
         </a>
         ) and discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4979.html" rel="external">
          "Neonatal thrombocytopenia: Etiology"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Doppler ultrasonography is the imaging test of choice to confirm the diagnosis of venous or arterial thrombosis in most cases. The advantages of ultrasound are that it is noninvasive, does not require exposure to ionizing radiation, and can be performed at the bedside. Alternative imaging modalities are available (eg, contrast angiography, contrast magnetic resonance imaging, computed tomography); however, they are rarely necessary.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Catheter-associated thrombosis
         </strong>
         – Noncompressibility of the vessel with or without visible intraluminal thrombus confirms the diagnosis of catheter-associated thrombosis on ultrasound. However, the presence of a catheter may impact the sensitivity of ultrasound for detecting thrombus since the catheter itself may reduce the compressibility of the vessel lumen, thereby making it difficult to definitely determine if a thrombus is present [
         <a href="#rid24">
          24
         </a>
         ]. In addition, preterm and critically ill neonates may have low pulse pressure, and therefore interpretation of the Doppler flow when assessing for an arterial thrombus can be challenging.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal vein thrombosis (RVT)
         </strong>
         – The ultrasound features of RVT depend upon the timing of the examination [
         <a href="#rid72">
          72-74
         </a>
         ]. During the first few days, echogenic streaks appear in a peripheral focal segment of the affected kidney. During the first week, the kidney appears swollen and echogenic, with prominent and less echogenic medullary pyramids. As the swelling decreases, the kidney appears heterogeneous with loss of corticomedullary differentiation. The kidney may subsequently atrophy with focal scarring or recover. Color Doppler ultrasonography may show absent intrarenal and renal venous flow in the early stages of RVT [
         <a href="#rid72">
          72
         </a>
         ]. Indeed, the sonographic findings can be used to predict outcome [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          ADDITIONAL TESTING
         </span>
        </p>
        <p class="headingAnchor" id="H492310331">
         <span class="h2">
          Testing for thrombophilia
         </span>
         <span class="headingEndMark">
          —
         </span>
         The utility of thrombophilia testing in neonates with thrombosis is uncertain. Inherited thrombophilias are associated with a risk of recurrence. However, among patients who present with thrombosis in the neonatal period, the risk of recurrence is low (3 to 5 percent) and it when it does occur, it is most often a distant event, occurring at the earliest in the teenage years [
         <a href="#rid25">
          25,76
         </a>
         ]. Consultation with a pediatric hematologist is advised when making decisions regarding testing for thrombophilia. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents", section on 'Children with venous thromboembolism'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Who to test
         </strong>
         – Decisions regarding testing for thrombophilia in newborns with clinically significant thrombosis are individualized. We generally do not perform testing in newborns with a single episode of catheter-related thrombosis, since the utility of testing in this setting is minimal [
         <a href="#rid77">
          77
         </a>
         ]. However, an evaluation for thrombophilia is generally warranted for patients with recurrent episodes and/or thrombosis unrelated to a catheter.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Timing of testing
         </strong>
         – Unless the thrombosis is severe or recurrent, we generally prefer to delay thrombophilia testing until the infant is older. This is because it is difficult to interpret non-DNA-based coagulation and fibrinolytic tests in the neonatal period and in the setting of acute thrombosis. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents", section on 'Timing of testing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tests to perform –
         </strong>
         When the decision is made to perform thrombophilia testing in a neonate, the tests to perform are generally the same as for older children, as summarized in the table (
         <a class="graphic graphic_table graphicRef88804" href="/z/d/graphic/88804.html" rel="external">
          table 3
         </a>
         ). The one difference is that testing for antiphospholipid antibodies should be performed on a maternal blood sample rather than testing the neonate. Thrombophilia testing in infants and children is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents", section on 'Tests to perform'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interpretation
         </strong>
         – Reference values for functional assays and tests that measure protein levels vary somewhat by age. Thus, results of these tests should be interpreted using reference values for the appropriate postnatal and gestational age [
         <a href="#rid78">
          78
         </a>
         ]. This limitation does not apply molecular tests (eg, DNA-based tests for factor V Leiden of prothrombin 20210 mutations).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Abnormal results should be repeated in four to six weeks, and parents should be counseled about the results.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3036061433">
         <span class="h2">
          Pretreatment evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         If anticoagulation therapy is planned, we suggest performing baseline pretreatment laboratory evaluation and cranial ultrasound. (See
         <a class="medical medical_review" href="/z/d/html/5911.html" rel="external">
          "Neonatal thrombosis: Management and outcome", section on 'Pretreatment evaluation'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory tests
         </strong>
         – Baseline pretreatment laboratory testing includes the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Activated partial thromboplastin time (aPTT)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prothrombin time (PT) and international normalized ratio (INR)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Plasma fibrinogen concentration
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Complete blood count, including platelet count
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Kidney function tests (blood urea nitrogen and creatinine)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Liver transaminases (if treatment with a direct oral anticoagulant [DOAC] is planned, which is uncommon)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pretreatment cranial ultrasound
         </strong>
         – We suggest performing a baseline pretreatment cranial ultrasound to rule out intracranial or intraventricular hemorrhage. This is especially important for preterm infants. (See
         <a class="medical medical_review" href="/z/d/html/5051.html" rel="external">
          "Germinal matrix and intraventricular hemorrhage (GMH-IVH) in the newborn: Risk factors, clinical features, screening, and diagnosis", section on 'Cranial ultrasound'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1995380647">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117261.html" rel="external">
          "Society guideline links: Thrombotic diseases in infants and children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17066672">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – In healthy newborns, thrombosis is rare, occurring in approximately 3 to 5 out of 100,000 live births. However, among patients admitted to the neonatal intensive care unit (NICU), approximately 1 percent develop thrombosis. Procoagulant, anticoagulant, and fibrinolytic factors differ considerably in neonates compared with older children and adults (
         <a class="graphic graphic_table graphicRef66999 graphicRef65080" href="/z/d/graphic/66999.html" rel="external">
          table 1A-B
         </a>
         ). As a result, newborns are at increased risk of both bleeding and thrombotic complications compared with older children, especially in the presence of other risk factors. Important risk factors for thrombosis in neonates include (see
         <a class="local">
          'Coagulation in newborns'
         </a>
         above and
         <a class="local">
          'Risk factors'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Central venous or arterial catheters
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polycythemia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infections
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Major surgery
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other underlying conditions (eg, metabolic disorders, congenital heart disease, congenital nephrotic syndrome)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inherited thrombophilia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Presentation
         </strong>
         – Most cases of neonatal thrombosis are asymptomatic. When present, signs and symptoms vary depending upon the location of the thrombus:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Catheter-associated thrombosis
         </strong>
         – A common presenting symptom of catheter-associated thrombosis is loss of catheter patency. If the thrombosis occludes the inferior vena cava or superior vena cava, the neonate may present with swelling and/or discoloration of the affected extremities. If the catheter tip is in the right atrium, a right atrial thrombosis can form, which may present as a new murmur or signs of heart failure. (See
         <a class="local">
          'Venous thrombosis'
         </a>
         above and
         <a class="local">
          'Right atrial thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Portal vein thrombosis (PVT)
         </strong>
         – PVT is a complication of umbilical vein catheterization. Most are asymptomatic and regress spontaneously. In a minority of patients, PVT may lead to hepatic lobar atrophy and/or portal hypertension. (See
         <a class="local">
          'Portal vein thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Arterial thrombosis
         </strong>
         – Arterial thrombosis in neonates is usually associated with indwelling arterial catheters. Thrombosis associated with umbilical artery catheters may be asymptomatic or may present with ischemia or organ dysfunction, depending on the location of the thrombus. Thrombosis associated with peripheral arterial catheters may present with decreased or absent peripheral pulses; diminished perfusion with a prolonged capillary refill time; and a cool, pale extremity. (See
         <a class="local">
          'Arterial thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Renal vein thrombosis (RVT)
         </strong>
         – RVT accounts for approximately 10 percent of venous thrombosis in newborns and is the most common form of thrombosis not associated with a vascular catheter. RVT typically presents with flank mass, hematuria, or thrombocytopenia. Risk factors for RVT include prematurity, perinatal asphyxia, dehydration, sepsis, polycythemia, cyanotic congenital heart disease, maternal diabetes, and inherited thrombophilia. (See
         <a class="local">
          'Renal vein thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Severe neonatal purpura
         </strong>
         – Neonatal purpura fulminans in newborns is a rare, life-threatening condition characterized by disseminated intravascular coagulation and hemorrhagic skin necrosis. It usually presents on the first day of life and is characterized by ecchymoses, extensive venous and arterial thromboses, laboratory evidence of disseminated intravascular coagulation, and extremely low levels of protein C or protein S antigen. (See
         <a class="local">
          'Purpura fulminans'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of venous or arterial thrombosis is confirmed by Doppler ultrasonography. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Testing for thrombophilia
         </strong>
         – Decisions regarding evaluation for thrombophilia in newborns with clinically significant thrombosis are made on a case-by-case basis. We pursue such testing only in neonates with recurrent or unprovoked (ie, not catheter-associated) thrombosis. If testing is performed, the results should be interpreted using reference values for the appropriate postnatal and gestational age. (See
         <a class="local">
          'Additional testing'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72:1651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80:1998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M, Schmidt B, Mitchell L, et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salonvaara M, Riikonen P, Kekomäki R, et al. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed 2003; 88:F319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76:F163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuckuviene R, Christensen AL, Helgestad J, et al. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011; 159:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sirachainan N, Limrungsikul A, Chuansumrit A, et al. Incidences, risk factors and outcomes of neonatal thromboembolism. J Matern Fetal Neonatal Med 2018; 31:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unal S, Gönülal D, Siyah Bilgin B, et al. Experience and Prognosis of Systemic Neonatal Thrombosis at a Level III NICU. J Pediatr Hematol Oncol 2018; 40:e410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhat R, Kumar R, Kwon S, et al. Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit-A Case Control Study. J Pediatr 2018; 195:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Naggar W, Yoon EW, McMillan D, et al. Epidemiology of thrombosis in Canadian neonatal intensive care units. J Perinatol 2020; 40:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haddad H, Lee KS, Higgins A, et al. Routine surveillance ultrasound for the management of central venous catheters in neonates. J Pediatr 2014; 164:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rizzi M, Goldenberg N, Bonduel M, et al. Catheter-Related Arterial Thrombosis in Neonates and Children: A Systematic Review. Thromb Haemost 2018; 118:1058.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubbink-Verheij GH, Pelsma ICM, van Ommen CH, et al. Femoral Vein Catheter is an Important Risk Factor for Catheter-related Thrombosis in (Near-)term Neonates. J Pediatr Hematol Oncol 2018; 40:e64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lambert I, Tarima S, Uhing M, Cohen SS. Risk Factors Linked to Central Catheter-Associated Thrombosis in Critically Ill Infants in the Neonatal Intensive Care Unit. Am J Perinatol 2019; 36:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barone G, D'Andrea V, Vento G, Pittiruti M. A Systematic Ultrasound Evaluation of the Diameter of Deep Veins in the Newborn: Results and Implications for Clinical Practice. Neonatology 2019; 115:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narang S, Roy J, Stevens TP, et al. Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants. Pediatr Blood Cancer 2009; 52:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Venkateswaran L, Scaglia F, McLin V, et al. Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis. Pediatr Blood Cancer 2009; 53:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amankwah EK, Atchison CM, Arlikar S, et al. Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit. Thromb Res 2014; 134:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edstrom CS, Christensen RD. Evaluation and treatment of thrombosis in the neonatal intensive care unit. Clin Perinatol 2000; 27:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology Am Soc Hematol Educ Program 2001; :358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008; 118:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kenet G, Maayan-Metzger A, Rosenberg N, et al. Thrombophilia does not increase risk for neonatal complications in preterm infants. Thromb Haemost 2003; 90:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanke RB, van Megen R, Daniëls O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994; 45:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roy M, Turner-Gomes S, Gill G, et al. Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. J Pediatr 2002; 140:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tieu P, Paes B, Ahmed A, et al. Inferior vena cava syndrome in neonates: An evidence-based systematic review of the literature. Pediatr Blood Cancer 2020; 67:e28114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kramer SS, Taylor GA, Garfinkel DJ, Simmons MA. Lethal chylothoraces due to superior vena caval thrombosis in infants. AJR Am J Roentgenol 1981; 137:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seibert JJ, Golladay ES, Keller C. Chylothorax secondary to superior vena caval obstruction. Pediatr Radiol 1982; 12:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engum SA, Rescorla FJ, West KW, et al. The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. J Pediatr Surg 1999; 34:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kooiman AM, Kootstra G, Zwierstra RP. Portal hypertension in children due to thrombosis of the portal vein. Neth J Surg 1982; 34:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Junker P, Egeblad M, Nielsen O, Kamper J. Umbilical vein catheterization and portal hypertension. Acta Paediatr Scand 1976; 65:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz DS, Gettner PA, Konstantino MM, et al. Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 1997; 131:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morag I, Epelman M, Daneman A, et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bersani I, Piersigilli F, Iacona G, et al. Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis. World J Hepatol 2021; 13:1802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cabannes M, Bouissou A, Favrais G, et al. Systematic ultrasound examinations in neonates admitted to NICU: evolution of portal vein thrombosis. J Perinatol 2018; 38:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang JH, Chung ML, Lim YJ. Incidence and risk factors of subclinical umbilical catheter-related thrombosis in neonates. Thromb Res 2020; 194:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubbink-Verheij GH, Visser R, Roest AA, et al. Thrombosis after umbilical venous catheterisation: prospective study with serial ultrasound. Arch Dis Child Fetal Neonatal Ed 2020; 105:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Giorgio A, De Angelis P, Cheli M, et al. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study. Dig Liver Dis 2019; 51:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams S, Chan AK. Neonatal portal vein thrombosis: diagnosis and management. Semin Fetal Neonatal Med 2011; 16:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morag I, Shah PS, Epelman M, et al. Childhood outcomes of neonates diagnosed with portal vein thrombosis. J Paediatr Child Health 2011; 47:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatt MD, Patel V, Butt ML, et al. Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy. Pediatr Blood Cancer 2019; 66:e27572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrari F, Vagnarelli F, Gargano G, et al. Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Child Fetal Neonatal Ed 2001; 85:F66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gibson K, Sharp R, Ullman A, et al. Adverse events associated with umbilical catheters: a systematic review and meta-analysis. J Perinatol 2021; 41:2505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg R, Waldman D, Brooks C, et al. Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization. J Vasc Surg 1998; 28:949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown MS, Phibbs RH. Spinal cord injury in newborns from use of umbilical artery catheters: report of two cases and a review of the literature. J Perinatol 1988; 8:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nagel K, Tuckuviene R, Paes B, Chan AK. Neonatal aortic thrombosis: a comprehensive review. Klin Padiatr 2010; 222:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macnicol MF, Anagnostopoulos J. Arrest of the growth plate after arterial cannulation in infancy. J Bone Joint Surg Br 2000; 82:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ouellette AC, Darling EK, Sivapathasundaram B, et al. Incidence, Risk Factors, and Outcomes of Neonatal Renal Vein Thrombosis in Ontario: Population-Based Cohort Study. Kidney360 2020; 1:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosch A, Kuwertz-Bröking E, Heller C, et al. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 2004; 104:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marks SD, Massicotte MP, Steele BT, et al. Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders. J Pediatr 2005; 146:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry. Thromb Haemost 2004; 92:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winyard PJ, Bharucha T, De Bruyn R, et al. Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed 2006; 91:F273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zigman A, Yazbeck S, Emil S, Nguyen L. Renal vein thrombosis: a 10-year review. J Pediatr Surg 2000; 35:1540.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau KK, Stoffman JM, Williams S, et al. Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006. Pediatrics 2007; 120:e1278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price VE, Ledingham DL, Krümpel A, Chan AK. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med 2011; 16:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seligsohn U, Berger A, Abend M, et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters C, Casella JF, Marlar RA, et al. Homozygous protein C deficiency: observations on the nature of the molecular abnormality and the effectiveness of warfarin therapy. Pediatrics 1988; 81:272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sugahara Y, Miura O, Yuen P, Aoki N. Protein C deficiency Hong Kong 1 and 2: hereditary protein C deficiency caused by two mutant alleles, a 5-nucleotide deletion and a missense mutation. Blood 1992; 80:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahasandana C, Suvatte V, Marlar RA, et al. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990; 335:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pung-amritt P, Poort SR, Vos HL, et al. Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency. Thromb Haemost 1999; 81:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuen P, Cheung A, Lin HJ, et al. Purpura fulminans in a Chinese boy with congenital protein C deficiency. Pediatrics 1986; 77:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2:1165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Estellés A, Garcia-Plaza I, Dasí A, et al. Severe inherited "homozygous" protein C deficiency in a newborn infant. Thromb Haemost 1984; 52:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sills RH, Marlar RA, Montgomery RR, et al. Severe homozygous protein C deficiency. J Pediatr 1984; 105:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rappaport ES, Speights VO, Helbert B, et al. Protein C deficiency. South Med J 1987; 80:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Limperger V, Klostermeier UC, Kenet G, et al. Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study. Br J Haematol 2014; 167:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuddenham EG, Takase T, Thomas AE, et al. Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb Res 1989; 53:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hibbert J, Howlett DC, Greenwood KL, et al. The ultrasound appearances of neonatal renal vein thrombosis. Br J Radiol 1997; 70:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cremin BJ, Davey H, Oleszczuk-Raszke K. Neonatal renal venous thrombosis: sequential ultrasonic appearances. Clin Radiol 1991; 44:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wright NB, Blanch G, Walkinshaw S, Pilling DW. Antenatal and neonatal renal vein thrombosis: new ultrasonic features with high frequency transducers. Pediatr Radiol 1996; 26:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kraft JK, Brandão LR, Navarro OM. Sonography of renal venous thrombosis in neonates and infants: can we predict outcome? Pediatr Radiol 2011; 41:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ommen CH, Heijboer H, Büller HR, et al. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turebylu R, Salis R, Erbe R, et al. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol 2007; 27:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74:415.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5912 Version 20.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3593964" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Development of the human coagulation system in the full-term infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3179444" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Development of the human coagulation system in the healthy premature infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1391957" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Maturation of the hemostatic system during childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8704247" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Evolution of blood coagulation activators and inhibitors in the healthy human fetus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2178462" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Development of the hemostatic system in the neonate and young infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2339359" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12819166" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7478839" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Neonatal thrombosis: report of a prospective Canadian and international registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9175945" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Neonatal symptomatic thromboembolism in Germany: two year survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21596390" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28110589" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Incidences, risk factors and outcomes of neonatal thromboembolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29750744" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Experience and Prognosis of Systemic Neonatal Thrombosis at a Level III NICU.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29398052" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit-A Case Control Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32385393" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Epidemiology of thrombosis in Canadian neonatal intensive care units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24112862" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Routine surveillance ultrasound for the management of central venous catheters in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29695022" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Catheter-Related Arterial Thrombosis in Neonates and Children: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29016413" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Femoral Vein Catheter is an Important Risk Factor for Catheter-related Thrombosis in (Near-)term Neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30081400" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risk Factors Linked to Central Catheter-Associated Thrombosis in Critically Ill Infants in the Neonatal Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30878998" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : A Systematic Ultrasound Evaluation of the Diameter of Deep Veins in the Newborn: Results and Implications for Clinical Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18680150" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19343772" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24953982" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10986632" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Evaluation and treatment of thrombosis in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11722993" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Thromboembolic disease and antithrombotic therapy in newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18779442" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14597976" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Thrombophilia does not increase risk for neonatal complications in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8203775" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Thrombus detection on central venous catheters in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11815778" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31876366" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Inferior vena cava syndrome in neonates: An evidence-based systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6792877" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Lethal chylothoraces due to superior vena caval thrombosis in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7177736" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Chylothorax secondary to superior vena caval obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10052806" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6981785" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Portal hypertension in children due to thrombosis of the portal vein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/937001" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Umbilical vein catheterization and portal hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403662" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Umbilical venous catheterization and the risk of portal vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16769378" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Portal vein thrombosis in the neonate: risk factors, course, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34904047" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30082773" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Systematic ultrasound examinations in neonates admitted to NICU: evolution of portal vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32563060" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Incidence and risk factors of subclinical umbilical catheter-related thrombosis in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31391204" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Thrombosis after umbilical venous catheterisation: prospective study with serial ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30928422" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21925985" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Neonatal portal vein thrombosis: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21309882" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Childhood outcomes of neonates diagnosed with portal vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30520242" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11420328" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34272469" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Adverse events associated with umbilical catheters: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9808866" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3057138" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Spinal cord injury in newborns from use of umbilical artery catheters: report of two cases and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20514615" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Neonatal aortic thrombosis: a comprehensive review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10755421" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Arrest of the growth plate after arterial cannulation in infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35372933" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Incidence, Risk Factors, and Outcomes of Neonatal Renal Vein Thrombosis in Ontario: Population-Based Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15150075" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15973324" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15467902" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : A case series of 72 neonates with renal vein thrombosis. Data from the 1-800-NO-CLOTS Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16464938" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Perinatal renal venous thrombosis: presenting renal length predicts outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11083418" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Renal vein thrombosis: a 10-year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17974721" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21839696" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diagnosis and management of neonatal purpura fulminans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6546411" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3838081" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3340476" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Homozygous protein C deficiency: observations on the nature of the molecular abnormality and the effectiveness of warfarin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1611081" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Protein C deficiency Hong Kong 1 and 2: hereditary protein C deficiency caused by two mutant alleles, a 5-nucleotide deletion and a missense mutation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1967377" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Neonatal purpura fulminans associated with homozygous protein S deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10063989" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Compound heterozygosity for one novel and one recurrent mutation in a Thai patient with severe protein S deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3754634" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Purpura fulminans in a Chinese boy with congenital protein C deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6139528" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6548587" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Severe inherited "homozygous" protein C deficiency in a newborn infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6547978" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Severe homozygous protein C deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3810223" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Protein C deficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25039884" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2660320" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9536915" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The ultrasound appearances of neonatal renal vein thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1873953" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Neonatal renal venous thrombosis: sequential ultrasonic appearances.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8781115" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Antenatal and neonatal renal vein thrombosis: new ultrasonic features with high frequency transducers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20734037" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Sonography of renal venous thrombosis in neonates and infants: can we predict outcome?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11713446" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17625574" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8578498" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Developmental hemostasis: relevance to thromboembolic complications in pediatric patients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
